Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 257

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Acellular and cellular approaches to improve diabetic wound healing

Cho, Hongkwan, Blatchley, Michael R., Duh, Elia J., Gerecht, Sharon·2019·Advanced Drug Delivery Reviews
DOI 10.1016/j.addr.2018.07.019
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2018.07.019

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 279

  1. Cavanagh, 2005, Treatment for diabetic foot ulcers, Lancet, 366, 1725, 10.1016/S0140-6736(05)67699-4 · DOI
  2. Gordois, 2003, The health care costs of diabetic peripheral neuropathy in the US, Diabetes Care, 26, 1790, 10.2337/diacare.26.6.1790 · DOI · Paper page
  3. Armstrong, 2017, Diabetic Foot Ulcers and Their Recurrence, N. Engl. J. Med., 376, 2367, 10.1056/NEJMra1615439 · DOI · Paper page
  4. Zhang, 2017, Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis dagger, Ann. Med., 49, 106, 10.1080/07853890.2016.1231932 · DOI
  5. Greenhalgh, 1998, The role of apoptosis in wound healing, Int. J. Biochem. Cell Biol., 30, 1019, 10.1016/S1357-2725(98)00058-2 · DOI · Paper page
  6. Minutti, 2017, Tissue-specific contribution of macrophages to wound healing, Semin. Cell Dev. Biol., 61, 3, 10.1016/j.semcdb.2016.08.006 · DOI · Paper page
  7. Frykberg, 2015, Challenges in the Treatment of Chronic Wounds, Adv Wound Care (New Rochelle), 4, 560, 10.1089/wound.2015.0635 · DOI · Paper page
  8. Bessman, 1992, Infections in the diabetic patient: the role of immune dysfunction and pathogen virulence factors, J. Diabetes Complicat., 6, 258, 10.1016/1056-8727(92)90062-P · DOI
  9. Demidova-Rice, 2012, Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care, Adv. Skin Wound Care, 25, 304, 10.1097/01.ASW.0000416006.55218.d0 · DOI · Paper page
  10. Sen, 2009, Wound healing essentials: let there be oxygen, Wound Repair Regen., 17, 1, 10.1111/j.1524-475X.2008.00436.x · DOI
  11. Birben, 2012, Oxidative stress and antioxidant defense, World Allergy Organ J., 5, 9, 10.1097/WOX.0b013e3182439613 · DOI · Paper page
  12. Rittie, 1999, Decreased contraction of glycated collagen lattices coincides with impaired matrix metalloproteinase production, Biochem. Biophys. Res. Commun., 264, 488, 10.1006/bbrc.1999.1519 · DOI
  13. Kuzuya, 1998, Inhibition of angiogenesis on glycated collagen lattices, Diabetologia, 41, 491, 10.1007/s001250050937 · DOI
  14. Lohwasser, 2006, The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha, J. Invest. Dermatol., 126, 291, 10.1038/sj.jid.5700070 · DOI
  15. Goldin, 2006, Advanced glycation end products: sparking the development of diabetic vascular injury, Circulation, 114, 597, 10.1161/CIRCULATIONAHA.106.621854 · DOI · Paper page
  16. Villeneuve, 2008, Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes, Proc. Natl. Acad. Sci. U. S. A., 105, 9047, 10.1073/pnas.0803623105 · DOI
  17. Zhong, 2010, Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon, J. Cell. Biochem., 110, 1306, 10.1002/jcb.22644 · DOI
  18. Akopian, 2006, Outcomes of conventional wound treatment in a comprehensive wound center, Am. Surg., 72, 314, 10.1177/000313480607200407 · DOI
  19. Falanga, 2005, Wound healing and its impairment in the diabetic foot, Lancet, 366, 1736, 10.1016/S0140-6736(05)67700-8 · DOI
  20. Keyser, 1993, Diabetic wound healing and limb salvage in an outpatient wound care program, South. Med. J., 86, 311, 10.1097/00007611-199303000-00013 · DOI
  21. Ramsey, 1999, Incidence, outcomes, and cost of foot ulcers in patients with diabetes, Diabetes Care, 22, 382, 10.2337/diacare.22.3.382 · DOI
  22. Steed, 1996, Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group, J. Am. Coll. Surg., 183, 61
  23. Embil, 2000, Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy, Wound Repair Regen., 8, 162, 10.1046/j.1524-475x.2000.00162.x · DOI
  24. Miller, 1999, Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers, J. Foot Ankle Surg., 38, 227, 10.1016/S1067-2516(99)80058-1 · DOI
  25. Wieman, 1998, Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study, Diabetes Care, 21, 822, 10.2337/diacare.21.5.822 · DOI
  26. Margolis, 2005, Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers, Wound Repair Regen., 13, 531, 10.1111/j.1524-475X.2005.00074.x · DOI
  27. Marston, 2004, Dermagraft (R), a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer, Expert Rev. Med. Devices, 1, 21, 10.1586/17434440.1.1.21 · DOI
  28. Dinh, 2006, The efficacy of Apligraf in the treatment of diabetic foot ulcers, Plast. Reconstr. Surg., 117, 152S, 10.1097/01.prs.0000222534.79915.d3 · DOI
  29. Papanas, 2010, Benefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers, Drug Saf., 33, 455, 10.2165/11534570-000000000-00000 · DOI
  30. Martinson, 2016, A comparative analysis of skin substitutes used in the management of diabetic foot ulcers, J. Wound Care, 25, S8, 10.12968/jowc.2016.25.Sup10.S8 · DOI
  31. Schultz, 2003, Wound bed preparation: a systematic approach to wound management, Wound Repair Regen., 11, S1, 10.1046/j.1524-475X.11.s2.1.x · DOI · Paper page
  32. Boateng, 2015, Advanced therapeutic dressings for effective wound healing—a review, J. Pharm. Sci., 104, 3653, 10.1002/jps.24610 · DOI
  33. Beer, 1997, Reduced expression of PDGF and PDGF receptors during impaired wound healing, J. Investig. Dermatol., 109, 132, 10.1111/1523-1747.ep12319188 · DOI · Paper page
  34. Schultz, 2009, Interactions between extracellular matrix and growth factors in wound healing, Wound Repair Regen., 17, 153, 10.1111/j.1524-475X.2009.00466.x · DOI · Paper page
  35. Dickinson, 2016, Engineered biopolymeric scaffolds for chronic wound healing, Front. Physiol., 7, 341, 10.3389/fphys.2016.00341 · DOI
  36. Zhong, 2010, Tissue scaffolds for skin wound healing and dermal reconstruction, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2, 510, 10.1002/wnan.100 · DOI · Paper page
  37. Nieuwdorp, 2007, Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis, Diabetologia, 50, 1288, 10.1007/s00125-007-0666-4 · DOI
  38. Stern, 2004, Hyaluronan catabolism: a new metabolic pathway, Eur. J. Cell Biol., 83, 317, 10.1078/0171-9335-00392 · DOI
  39. Bohn, 2016, Ovine-based collagen matrix dressing: next-generation collagen dressing for wound care, Adv Wound Care (New Rochelle), 5, 1, 10.1089/wound.2015.0660 · DOI
  40. Holmes, 2013, Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review, Diabetes Metab. Syndr. Obes., 6, 17, 10.2147/DMSO.S36024 · DOI
  41. Brennan, 2006, Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix, Tissue Eng., 12, 2949, 10.1089/ten.2006.12.2949 · DOI
  42. Briquez, 2015, Extracellular matrix-inspired growth factor delivery systems for skin wound healing, Adv Wound Care (New Rochelle), 4, 479, 10.1089/wound.2014.0603 · DOI
  43. Reyzelman, 2009, Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study, Int. Wound J., 6, 196, 10.1111/j.1742-481X.2009.00585.x · DOI · Paper page
  44. Brigido, 2006, The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study, Int. Wound J., 3, 181, 10.1111/j.1742-481X.2006.00209.x · DOI
  45. Cazzell, 2015, The management of diabetic foot ulcers with porcine small intestine submucosa tri-layer matrix: a randomized controlled trial, Adv. Wound Care (New Rochelle), 4, 711, 10.1089/wound.2015.0645 · DOI · Paper page
  46. Guest, 2017, Cost-effectiveness of using adjunctive porcine small intestine submucosa tri-layer matrix compared with standard care in managing diabetic foot ulcers in the US, J. Wound Care, 26, S12, 10.12968/jowc.2017.26.Sup1.S12 · DOI
  47. Niezgoda, 2005, Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers, Adv. Skin Wound Care, 18, 258, 10.1097/00129334-200506000-00012 · DOI
  48. Frykberg, 2016, Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis, J. Wound Care, 25, S18, 10.12968/jowc.2016.25.Sup7.S18 · DOI
  49. Lecheminant, 2012, Porcine urinary bladder matrix: a retrospective study and establishment of protocol, J. Wound Care, 21, 478
  50. Hodde, 1996, Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement, Tissue Eng., 2, 209, 10.1089/ten.1996.2.209 · DOI
  51. McDevitt, 2003, Transforming growth factor-beta1 in a sterilized tissue derived from the pig small intestine submucosa, J. Biomed. Mater. Res. A, 67, 637, 10.1002/jbm.a.10144 · DOI
  52. Hodde, 2005, An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix, J. Wound Care, 14, 23, 10.12968/jowc.2005.14.1.26721 · DOI
  53. Hodde, 2001, Vascular endothelial growth factor in porcine-derived extracellular matrix, Endothelium, 8, 11, 10.3109/10623320109063154 · DOI
  54. Hodde, 2001, Bioactive FGF-2 in sterilized extracellular matrix, Wounds, 13, 195
  55. Liang, 2011, Alpha1,3-galactosyltransferase knockout does not alter the properties of porcine extracellular matrix bioscaffolds, Acta Biomater., 7, 1719, 10.1016/j.actbio.2011.01.001 · DOI
  56. Turner, 2015, The use of biologic scaffolds in the treatment of chronic nonhealing wounds, Adv Wound Care (New Rochelle), 4, 490, 10.1089/wound.2014.0604 · DOI
  57. Brown, 2006, The basement membrane component of biologic scaffolds derived from extracellular matrix, Tissue Eng., 12, 519, 10.1089/ten.2006.12.519 · DOI
  58. Kimmel, 2010, The clinical effectiveness in wound healing with extracellular matrix derived from porcine urinary bladder matrix: a case series on severe chronic wounds, J. Am. Col. Certif Wound Spec., 2, 55
  59. Kavros, 2014, The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study, Adv. Skin Wound Care, 27, 356, 10.1097/01.ASW.0000451891.87020.69 · DOI
  60. Kahn, 2011, Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wounds, J. Burn Care Res., 32, 124, 10.1097/BCR.0b013e318204b327 · DOI
  61. Strauss, 2012, Fetal bovine dermal repair scaffold used for the treatment of difficult-to- heal complex wounds, Wounds, 24, 327
  62. Ramshaw, 1986, Distribution of type Iii collagen in bovine skin of various ages, Connect. Tissue Res., 14, 307, 10.3109/03008208609017473 · DOI
  63. Volk, 2011, Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing, Cells Tissues Organs, 194, 25, 10.1159/000322399 · DOI
  64. Karr, 2011, Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf), Adv. Skin Wound Care, 24, 119, 10.1097/01.ASW.0000395038.28398.88 · DOI
  65. Gilbert, 2009, Quantification of DNA in biologic scaffold materials, J. Surg. Res., 152, 135, 10.1016/j.jss.2008.02.013 · DOI · Paper page
  66. Galili, 2005, The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy, Immunol. Cell Biol., 83, 674, 10.1111/j.1440-1711.2005.01366.x · DOI
  67. Choi, 2012, Decellularized extracellular matrix derived from porcine adipose tissue as a xenogeneic biomaterial for tissue engineering, Tissue Eng. Part C Methods, 18, 866, 10.1089/ten.tec.2012.0009 · DOI
  68. Kim, 2012, Recellularization of decellularized human adipose-tissue-derived extracellular matrix sheets with other human cell types, Cell Tissue Res., 348, 559, 10.1007/s00441-012-1391-y · DOI
  69. Wu, 2012, An injectable adipose matrix for soft-tissue reconstruction, Plast. Reconstr. Surg., 129, 1247, 10.1097/PRS.0b013e31824ec3dc · DOI
  70. Choi, 2009, Human extracellular matrix (ECM) powders for injectable cell delivery and adipose tissue engineering, J. Control. Release, 139, 2, 10.1016/j.jconrel.2009.05.034 · DOI
  71. Hoganson, 2016, Decellularized extracellular matrix microparticles as a vehicle for cellular delivery in a model of anastomosis healing, J. Biomed. Mater. Res. A, 104, 1728, 10.1002/jbm.a.35703 · DOI
  72. Okamoto, 2003, Effects of chitin and chitosan on blood coagulation, Carbohydr. Polym., 53, 337, 10.1016/S0144-8617(03)00076-6 · DOI
  73. Ueno, 2001, Topical formulations and wound healing applications of chitosan, Adv. Drug Deliv. Rev., 52, 105, 10.1016/S0169-409X(01)00189-2 · DOI
  74. Rabea, 2003, Chitosan as antimicrobial agent: applications and mode of action, Biomacromolecules, 4, 1457, 10.1021/bm034130m · DOI · Paper page
  75. Lipsky, 2004, Diagnosis and treatment of diabetic foot infections, Clin. Infect. Dis., 39, 885, 10.1086/424846 · DOI
  76. DeLeon, 2014, Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model, Infect. Immun., 82, 4718, 10.1128/IAI.02198-14 · DOI
  77. Tin, 2009, Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa, Int. J. Biol. Sci., 5, 153, 10.7150/ijbs.5.153 · DOI
  78. Rinaudo, 2006, Chitin and chitosan: properties and applications, Prog. Polym. Sci., 31, 603, 10.1016/j.progpolymsci.2006.06.001 · DOI
  79. Kojima, 2004, Effects of chitin and chitosan on collagen synthesis in wound healing, J. Vet. Med. Sci., 66, 1595, 10.1292/jvms.66.1595 · DOI
  80. Nguyen, 2013, Curcumin-loaded chitosan/gelatin composite sponge for wound healing application, Int. J. Polym. Sci., 2013, 7, 10.1155/2013/106570 · DOI
  81. Chiono, 2009, Chapter 9 artificial scaffolds for peripheral nerve reconstruction, 173, 10.1016/S0074-7742(09)87009-8 · DOI
  82. Elgadir, 2015, Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review, J. Food Drug Anal., 23, 619, 10.1016/j.jfda.2014.10.008 · DOI
  83. Charernsriwilaiwat, 2012, Lysozyme-loaded, electrospun chitosan-based nanofiber mats for wound healing, Int. J. Pharm., 427, 379, 10.1016/j.ijpharm.2012.02.010 · DOI
  84. Sun, 2011, Preparations, properties and applications of chitosan based nanofibers fabricated by electrospinning, Express Polym. Lett., 5, 342, 10.3144/expresspolymlett.2011.34 · DOI
  85. Zhao, 2011, Preparation and application of chitosan nanoparticles and nanofibers, Braz. J. Chem. Eng., 28, 353, 10.1590/S0104-66322011000300001 · DOI · Paper page
  86. Wang, 2015, Calcium alginate enhances wound healing by up-regulating the ratio of collagen types I/III in diabetic rats, Int. J. Clin. Exp. Pathol., 8, 6636
  87. Krisp, 2013, Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients, Proteomics, 13, 2670, 10.1002/pmic.201200502 · DOI · Paper page
  88. Segal, 1998, The effects of alginate and non-alginate wound dressings on blood coagulation and platelet activation, J. Biomater. Appl., 12, 249, 10.1177/088532829801200305 · DOI
  89. Pirone, 1992, Effect of calcium alginate dressings on partial-thickness wounds in swine, J. Investig. Surg., 5, 149, 10.3109/08941939209012431 · DOI
  90. Silva, 2008, Material-based deployment enhances efficacy of endothelial progenitor cells, Proc. Natl. Acad. Sci. U. S. A., 105, 14347, 10.1073/pnas.0803873105 · DOI
  91. Borselli, 2011, The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration, Biomaterials, 32, 8905, 10.1016/j.biomaterials.2011.08.019 · DOI
  92. Lee, 2012, Alginate: properties and biomedical applications, Prog. Polym. Sci., 37, 106, 10.1016/j.progpolymsci.2011.06.003 · DOI
  93. Tellechea, 2015, Alginate and DNA Gels Are Suitable Delivery Systems for Diabetic Wound Healing, Int J Low Extrem Wounds, 14, 146, 10.1177/1534734615580018 · DOI
  94. Sun, 2013, Alginate-based biomaterials for regenerative medicine applications, Materials, 6, 1285, 10.3390/ma6041285 · DOI · Paper page
  95. Augst, 2006, Alginate hydrogels as biomaterials, Macromol. Biosci., 6, 623, 10.1002/mabi.200600069 · DOI
  96. Gu, 2004, Sustained delivery of vascular endothelial growth factor with alginate beads, J. Control. Release, 96, 463, 10.1016/j.jconrel.2004.02.021 · DOI
  97. Wee, 1998, Protein release from alginate matrices, Adv. Drug Deliv. Rev., 31, 267, 10.1016/S0169-409X(97)00124-5 · DOI
  98. Laham, 1999, Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial, Circulation, 100, 1865, 10.1161/01.CIR.100.18.1865 · DOI
  99. Lee, 2003, Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice, J. Control. Release, 87, 49, 10.1016/S0168-3659(02)00349-8 · DOI
  100. Elcin, 2001, Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing, Artif. Organs, 25, 558, 10.1046/j.1525-1594.2001.025007558.x · DOI
  101. Jay, 2009, Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking, J. Control. Release, 134, 26, 10.1016/j.jconrel.2008.10.019 · DOI
  102. Cho, 2012, Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers, Acta Biomater., 8, 154, 10.1016/j.actbio.2011.08.029 · DOI
  103. Balaji, 2012, Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing, Wound Repair Regen., 20, 15, 10.1111/j.1524-475X.2011.00750.x · DOI
  104. Hurley, 2014, Nanofiber microenvironment effectively restores angiogenic potential of diabetic endothelial cells, Adv. Wound Care (New Rochelle), 3, 717, 10.1089/wound.2013.0511 · DOI
  105. Kim, 2018, Skin regeneration with self-assembled peptide hydrogels conjugated with substance P in a diabetic rat model, Tissue Eng. Part A, 24, 21, 10.1089/ten.tea.2016.0517 · DOI
  106. Zhang, 2005, Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures, Semin. Cancer Biol., 15, 413, 10.1016/j.semcancer.2005.05.007 · DOI
  107. Zhang, 2003, Fabrication of novel biomaterials through molecular self-assembly, Nat. Biotechnol., 21, 1171, 10.1038/nbt874 · DOI · Paper page
  108. Caplan, 2002, Control of self-assembling oligopeptide matrix formation through systematic variation of amino acid sequence, Biomaterials, 23, 219, 10.1016/S0142-9612(01)00099-0 · DOI
  109. Koutsopoulos, 2016, Self-assembling peptide nanofiber hydrogels in tissue engineering and regenerative medicine: progress, design guidelines, and applications, J. Biomed. Mater. Res. A, 104, 1002, 10.1002/jbm.a.35638 · DOI
  110. Nagai, 2006, Slow release of molecules in self-assembling peptide nanofiber scaffold, J. Control. Release, 115, 18, 10.1016/j.jconrel.2006.06.031 · DOI · Paper page
  111. Koutsopoulos, 2012, Two-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies, J. Control. Release, 160, 451, 10.1016/j.jconrel.2012.03.014 · DOI
  112. Koutsopoulos, 2009, Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold, Proc. Natl. Acad. Sci. U. S. A., 106, 4623, 10.1073/pnas.0807506106 · DOI
  113. Davis, 2006, Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction, Proc. Natl. Acad. Sci. U. S. A., 103, 8155, 10.1073/pnas.0602877103 · DOI
  114. Segers, 2007, Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction, Circulation, 116, 1683, 10.1161/CIRCULATIONAHA.107.718718 · DOI
  115. Bradshaw, 2014, Designer self-assembling hydrogel scaffolds can impact skin cell proliferation and migration, Sci. Rep., 4, 6903, 10.1038/srep06903 · DOI
  116. Kumar, 2011, Self-assembling peptides: implications for patenting in drug delivery and tissue engineering, Recent Pat. Drug Deliv. Formul., 5, 24, 10.2174/187221111794109510 · DOI
  117. Veiga, 2012, Arginine-rich self-assembling peptides as potent antibacterial gels, Biomaterials, 33, 8907, 10.1016/j.biomaterials.2012.08.046 · DOI
  118. Cutrona, 2015, Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptides, FEBS Lett., 589, 3915, 10.1016/j.febslet.2015.11.002 · DOI
  119. Deslouches, 2016, Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine, J. Med. Microbiol., 65, 554, 10.1099/jmm.0.000258 · DOI
  120. Tripathi, 2015, Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties, Biomaterials, 56, 92, 10.1016/j.biomaterials.2015.03.046 · DOI
  121. Jiang, 2015, Self-assembly of cationic multidomain peptide hydrogels: supramolecular nanostructure and rheological properties dictate antimicrobial activity, Nanoscale, 7, 19160, 10.1039/C5NR05233E · DOI
  122. Stratton, 2016, Bioactive polymeric scaffolds for tissue engineering, Bioactive Mater., 1, 93, 10.1016/j.bioactmat.2016.11.001 · DOI · Paper page
  123. Sundaramurthi, 2014, Electrospun nanofibers as scaffolds for skin tissue engineering, Polym. Rev., 54, 348, 10.1080/15583724.2014.881374 · DOI
  124. Shelke, 2014, Chapter 7 - polyurethanes, 123
  125. Janik, 2015, A review: fabrication of porous polyurethane scaffolds, Mater. Sci. Eng. C, 48, 586, 10.1016/j.msec.2014.12.037 · DOI
  126. Santoro, 2016, Poly(lactic acid) nanofibrous scaffolds for tissue engineering, Adv. Drug Deliv. Rev., 107, 206, 10.1016/j.addr.2016.04.019 · DOI · Paper page
  127. Marin, 2013, Critical evaluation of biodegradable polymers used in nanodrugs, Int. J. Nanomedicine, 8, 3071
  128. Chereddy, 2016, PLGA based drug delivery systems: promising carriers for wound healing activity, Wound Repair Regen., 24, 223, 10.1111/wrr.12404 · DOI · Paper page
  129. Etulain, 2018, An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties, Sci. Rep., 8, 1513, 10.1038/s41598-018-19419-6 · DOI
  130. Qiu, 2016, Platelet-rich plasma-loaded poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide) hydrogel dressing promotes full-thickness skin wound healing in a rodent model, Int. J. Mol. Sci., 17, 10.3390/ijms17071001 · DOI
  131. Kontogiannopoulos, 2011, Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications, Int. J. Pharm., 409, 216, 10.1016/j.ijpharm.2011.02.004 · DOI
  132. Nguyen, 2013, Characteristics of curcumin-loaded poly (lactic acid) nanofibers for wound healing, J. Mater. Sci., 48, 7125, 10.1007/s10853-013-7527-y · DOI
  133. Mohiti-Asli, 2017, Ibuprofen loaded PLA nanofibrous scaffolds increase proliferation of human skin cells in vitro and promote healing of full thickness incision wounds in vivo, J. Biomed. Mater. Res. B Appl. Biomater., 105, 327, 10.1002/jbm.b.33520 · DOI
  134. Thakur, 2008, Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing, Int. J. Pharm., 364, 87, 10.1016/j.ijpharm.2008.07.033 · DOI
  135. Zahedi, 2012, Preparation and performance evaluation of tetracycline hydrochloride loaded wound dressing mats based on electrospun nanofibrous poly(lactic acid)/poly(ϵ-caprolactone) blends, J. Appl. Polym. Sci., 124, 4174, 10.1002/app.35372 · DOI
  136. Kobsa, 2013, An electrospun scaffold integrating nucleic acid delivery for treatment of full-thickness wounds, Biomaterials, 34, 3891, 10.1016/j.biomaterials.2013.02.016 · DOI
  137. Sidhu, 1999, Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice, Wound Repair Regen., 7, 362, 10.1046/j.1524-475X.1999.00362.x · DOI
  138. Parani, 2016, Engineered nanomaterials for infection control and healing acute and chronic wounds, ACS Appl. Mater. Interfaces, 8, 10049, 10.1021/acsami.6b00291 · DOI · Paper page
  139. Merrell, 2009, Curcumin-loaded poly(epsilon-caprolactone) nanofibres: diabetic wound dressing with anti-oxidant and anti-inflammatory properties, Clin. Exp. Pharmacol. Physiol., 36, 1149, 10.1111/j.1440-1681.2009.05216.x · DOI
  140. Chereddy, 2013, Combined effect of PLGA and curcumin on wound healing activity, J. Control. Release, 171, 208, 10.1016/j.jconrel.2013.07.015 · DOI · Paper page
  141. Zahedi, 2010, A review on wound dressings with an emphasis on electrospun nanofibrous polymeric bandages, Polym. Adv. Technol., 21, 77, 10.1002/pat.1625 · DOI
  142. Zhang, 2017, Electrospun nanofibres containing antimicrobial plant extracts, Nanomaterials (Basel), 7, 10.3390/nano7020042 · DOI
  143. Beckert, 2006, Lactate stimulates endothelial cell migration, Wound Repair Regen., 14, 321, 10.1111/j.1743-6109.2006.00127.x · DOI
  144. Milovanova, 2008, Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1, Mol. Cell. Biol., 28, 6248, 10.1128/MCB.00795-08 · DOI
  145. Hunt, 2007, Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms, Antioxid. Redox Signal., 9, 1115, 10.1089/ars.2007.1674 · DOI
  146. Porporato, 2012, Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice, Angiogenesis, 15, 581, 10.1007/s10456-012-9282-0 · DOI · Paper page
  147. Mondal, 2016, Polycaprolactone-based biomaterials for tissue engineering and drug delivery: Current scenario and challenges, Int. J. Polym. Mater. Polym. Biomater., 65, 255, 10.1080/00914037.2015.1103241 · DOI
  148. Kim, 2006, An improved hydrophilicity via electrospinning for enhanced cell attachment and proliferation, J. Biomed. Mater. Res. B Appl. Biomater., 78, 283, 10.1002/jbm.b.30484 · DOI · Paper page
  149. Xie, 2010, Radially aligned, electrospun nanofibers as dural substitutes for wound closure and tissue regeneration applications, ACS Nano, 4, 5027, 10.1021/nn101554u · DOI
  150. Teo, 2011, Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds, Biomaterials, 32, 279, 10.1016/j.biomaterials.2010.08.089 · DOI
  151. Varma, 2006, Efficacy of polyurethane foam dressing in debrided diabetic lower limb wounds, Wounds, 18, 300
  152. Lakshman, 2010, Preparation of silver nanoparticles incorporated electrospun polyurethane nano-fibrous mat for wound dressing, J. Macromol. Sci. A, 47, 1012, 10.1080/10601325.2010.508001 · DOI
  153. Gogolewski, 1983, An artificial skin based on biodegradable mixtures of polylactides and polyurethanes for full-thickness skin wound covering, Die Makromolekulare Chemie, Rapid Communications, 4, 675, 10.1002/marc.1983.030041008 · DOI
  154. Pyun, 2015, Evaluation of AgHAP-containing polyurethane foam dressing for wound healing: synthesis, characterization, in vitro and in vivo studies, J. Mater. Chem. B, 3, 7752, 10.1039/C5TB00995B · DOI
  155. Abdollahi, 2015, Synthesis and characterization of curcumin segmented polyurethane with induced antiplatelet activity, J. Polym. Res., 22, 179, 10.1007/s10965-015-0824-1 · DOI
  156. Khil, 2003, Electrospun nanofibrous polyurethane membrane as wound dressing, J. Biomed. Mater. Res. B Appl. Biomater., 67, 675, 10.1002/jbm.b.10058 · DOI · Paper page
  157. Asefnejad, 2011, Manufacturing of biodegradable polyurethane scaffolds based on polycaprolactone using a phase separation method: physical properties and in vitro assay, Int. J. Nanomedicine, 6, 2375, 10.2147/IJN.S15586 · DOI
  158. Adolph, 2012, Injectable polyurethane composite scaffolds delay wound contraction and support cellular infiltration and remodeling in rat excisional wounds, J. Biomed. Mater. Res. A, 100, 450, 10.1002/jbm.a.33266 · DOI
  159. Choi, 2017, AgNP and rhEGF-incorporating synergistic polyurethane foam as a dressing material for scar-free healing of diabetic wounds, RSC Adv., 7, 13714, 10.1039/C6RA27322J · DOI
  160. Li, 2009, The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds, Biomaterials, 30, 3486, 10.1016/j.biomaterials.2009.03.008 · DOI
  161. Pyun Do, 2015, Polyurethane foam containing rhEGF as a dressing material for healing diabetic wounds: synthesis, characterization, in vitro and in vivo studies, Colloids Surf. B Biointerfaces, 135, 699, 10.1016/j.colsurfb.2015.08.029 · DOI
  162. Nelson, 2014, Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo, Adv. Mater., 26, 607, 10.1002/adma.201303520 · DOI
  163. Shen, 2009, Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice, J. Orthop. Res., 27, 1298, 10.1002/jor.20886 · DOI
  164. Nelson, 2013, siRNA delivery from an injectable scaffold for wound therapy, Adv. Wound Care (New Rochelle), 2, 93, 10.1089/wound.2011.0327 · DOI
  165. Park, 2014, Hypoxia-inducible hydrogels, Nat. Commun., 5, 4075, 10.1038/ncomms5075 · DOI
  166. Park, 2014, The design of dextran-based hypoxia-inducible hydrogels via in situ oxygen-consuming reaction, Macromol. Rapid Commun., 35, 1968, 10.1002/marc.201400369 · DOI
  167. Rasik, 2000, Antioxidant status in delayed healing type of wounds, Int. J. Exp. Pathol., 81, 257, 10.1046/j.1365-2613.2000.00158.x · DOI
  168. Mudge, 2002, Role of glutathione redox dysfunction in diabetic wounds, Wound Repair Regen., 10, 52, 10.1046/j.1524-475X.2002.10803.x · DOI
  169. Kim, 2012, Dysfunction of endothelial progenitor cells under diabetic conditions and its underlying mechanisms, Arch. Pharm. Res., 35, 223, 10.1007/s12272-012-0203-y · DOI
  170. Lin, 2012, Evaluation of topical tocopherol cream on cutaneous wound healing in streptozotocin-induced diabetic rats, Evid. Based Complement. Alternat. Med., 2012, 491027, 10.1155/2012/491027 · DOI
  171. van Lith, 2014, Engineering biodegradable polyester elastomers with antioxidant properties to attenuate oxidative stress in tissues, Biomaterials, 35, 8113, 10.1016/j.biomaterials.2014.06.004 · DOI
  172. Xiao, 2017, A cooperative copper metal-organic framework-hydrogel system improves wound healing in diabetes, Adv. Funct. Mater., 27, 10.1002/adfm.201604872 · DOI
  173. Zhu, 2016, Sustained release of stromal cell derived factor-1 from an antioxidant thermoresponsive hydrogel enhances dermal wound healing in diabetes, J. Control. Release, 238, 114, 10.1016/j.jconrel.2016.07.043 · DOI
  174. Kurahashi, 2015, Roles of antioxidative enzymes in wound healing, J. Dev. Biol., 3, 10.3390/jdb3020057 · DOI
  175. Churgin, 2005, Therapeutic administration of superoxide dismutase (SOD) mimetics normalizes wound healing in diabetic mice, J. Am. Coll. Surg., 201, S57, 10.1016/j.jamcollsurg.2005.06.124 · DOI
  176. Doctrow, 2013, A synthetic superoxide dismutase/catalase mimetic EUK-207 mitigates radiation dermatitis and promotes wound healing in irradiated rat skin, J. Investig. Dermatol., 133, 1088, 10.1038/jid.2012.410 · DOI
  177. Dhall, 2014, Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters, J. Diabetes Res., 2014, 562625, 10.1155/2014/562625 · DOI
  178. Rasik, 2000, Antioxidant status in delayed healing type of wounds, Int. J. Exp. Pathol., 81, 257, 10.1046/j.1365-2613.2000.00158.x · DOI
  179. Soares, 2016, Restoration of Nrf2 signaling normalizes the regenerative niche, Diabetes, 65, 633, 10.2337/db15-0453 · DOI
  180. Long, 2016, An essential role of NRF2 in diabetic wound healing, Diabetes, 65, 780, 10.2337/db15-0564 · DOI · Paper page
  181. Kaspar, 2009, Nrf2:INrf2 (Keap1) signaling in oxidative stress, Free Radic. Biol. Med., 47, 1304, 10.1016/j.freeradbiomed.2009.07.035 · DOI · Paper page
  182. Harvey, 2011, Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model, Sci. Transl. Med., 3, 10.1126/scitranslmed.3002042 · DOI · Paper page
  183. Gazaryan, 2016, The status of Nrf2-based therapeutics: current perspectives and future prospects, Neural Regen. Res., 11, 1708, 10.4103/1673-5374.194706 · DOI
  184. Kirby, 2015, Stem Cells for Cutaneous Wound Healing, Biomed. Res. Int., 11
  185. Eming, 2014, Wound repair and regeneration: Mechanisms, signaling, and translation, Sci. Transl. Med., 6, 16, 10.1126/scitranslmed.3009337 · DOI · Paper page
  186. Baltzis, 2014, Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights, Adv. Ther., 31, 817, 10.1007/s12325-014-0140-x · DOI
  187. Trengove, 1999, Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors, Wound Repair Regen., 7, 442, 10.1046/j.1524-475X.1999.00442.x · DOI · Paper page
  188. Lerman, 2003, Cellular dysfunction in the diabetic fibroblast - Impairment in migration, vascular endothelial growth factor production, and response to hypoxia, Am. J. Pathol., 162, 303, 10.1016/S0002-9440(10)63821-7 · DOI
  189. Agren, 1999, Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent, J. Investig. Dermatol., 112, 463
  190. Lal, 2003, Altered proliferative responses of dermal fibroblasts to TGF-beta(1) may contribute to chronic venous stasis ulcer, J. Vasc. Surg., 37, 1285, 10.1016/S0741-5214(02)75295-6 · DOI
  191. Blumberg, 2012, The role of stem cells in the treatment of diabetic foot ulcers, Diabetes Res. Clin. Pract., 96, 1, 10.1016/j.diabres.2011.10.032 · DOI
  192. Teraa, 2013, Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients, PLoS One, 8, 10, 10.1371/journal.pone.0055592 · DOI
  193. Tepper, 2010, Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1 alpha mediated bone marrow mobilization impair diabetic tissue repair, Diabetes, 59, 1974, 10.2337/db09-0185 · DOI
  194. Tepper, 2002, Human endothelial progenitor exhibit impaired proliferation, cells from type II diabetics adhesion, and incorporation into vascular structures, Circulation, 106, 2781, 10.1161/01.CIR.0000039526.42991.93 · DOI · Paper page
  195. Loomans, 2004, Endothelial progenitor cell dysfunction - a novel concept in the pathogenesis of vascular complications of type 1 diabetes, Diabetes, 53, 195, 10.2337/diabetes.53.1.195 · DOI
  196. Stojadinovic, 2014, Deregulation of epidermal stem cell niche contributes to pathogenesis of nonhealing venous ulcers, Wound Repair Regen., 22, 220, 10.1111/wrr.12142 · DOI
  197. Humpert, 2005, Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient, Exp. Clin. Endocrinol. Diabetes, 113, 538, 10.1055/s-2005-872886 · DOI
  198. Lu, 2011, Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial, Diabetes Res. Clin. Pract., 92, 26, 10.1016/j.diabres.2010.12.010 · DOI
  199. Iwase, 2005, Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia, Cardiovasc. Res., 66, 543, 10.1016/j.cardiores.2005.02.006 · DOI
  200. Inoue, 2008, Bioimaging assessment and effect of skin wound healing using bone-marrow-derived mesenchymal stromal cells with the artificial dermis in diabetic rats, J. Biomed. Opt., 13, 10, 10.1117/1.3042266 · DOI

200 of 279 shown

Cited by

See all 257

Metadata

Authors
Cho, H., Blatchley, M. R., Duh, E. J., & Gerecht, S.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2019-06
Volume
146
Pages
267-288
ISSN
0169-409X
DOI
10.1016/j.addr.2018.07.019
Cited by
257
References
24
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.